A controlled trial of bicalutamide versus flutamide, each in combination with luteinizing hormone-releasing hormone analogue therapy, in patients with advanced prostate cancer

Urology

Volumn 48, Issue 4, 1996, Pages 661-662

  Zerbib, M ^a   Payan, C ^b  

^a Cochin Hospital Paris ^*  (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIANDROGEN; BICALUTAMIDE; FLUTAMIDE; GONADORELIN AGONIST; GOSERELIN; LEUPRORELIN;

ADVANCED CANCER; CANCER HORMONE THERAPY; CLINICAL TRIAL; DATA ANALYSIS; DRUG EFFICACY; HUMAN; LETTER; PRIORITY JOURNAL; PROSTATE CANCER;

ANDROGEN ANTAGONISTS; ANILIDES; ANTINEOPLASTIC AGENTS, HORMONAL; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CONTROLLED CLINICAL TRIALS; FLUTAMIDE; GONADOTROPIN-RELEASING HORMONE; HUMANS; MALE; PROSTATIC NEOPLASMS;

EID: 0029957228     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0090-4295(96)80033-1     Document Type: Article

References (3)

1. Crawford ED, Eisenberger MA, McLeod DG, Spaulding JT, Benson R, Dorr FA, Blumenstein BA, Davis MA, and Goodman PJ: A controlled trial of leuprolide with and without flutamide in prostatic carcinoma. N Engl J Med 321: 419-424, 1989.
2. Denis LJ, Carnelro de Maura JL, Bono A, Sylvester R, Whelan P, Newling D, and Depauw M: Goserelin acetate and flutamide versus bilateral orchiectomy: a phase III EORTC trial (30 853). Urology 42: 119-130, 1993.
3. Simon R: Design and conduct of clinical trials, in De Vita VT, Hellman S, and Rosenberg SA (Eds): Cancer: Principles and Practice of Oncology, 4th ed. Philadelphia, JB Lippincott, 1993, pp 418-440.